Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy

World Journal of Gastroenterology

Volumn 22, Issue 33, 2016, Pages 7613-7624

  Moris, Demetrios ^a   Vernadakis, Spyridon ^b   Papalampros, Alexandros ^b   Vailas, Michail ^b   Dimitrokallis, Nikolaos ^b   Petrou, Athanasios ^b   Dimitroulis, Dimitrios ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Associating liver partition with portal vein ligation for staged hepatectomy; Liver regeneration; Liver transection; Portal vein embolization; Portal vein ligation

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; SCATTER FACTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULOTROPIN; CYTOKINE;

ARTICLE; ASSOCIATING LIVER PARTITION AND PORTAL VEIN LIGATION FOR STAGED HEPATECTOMY; CANCER SURGERY; CELL CYCLE REGULATION; CELL PROLIFERATION; CYTOKINE RELEASE; HEPATITIS; HUMAN; LIVER CELL; LIVER HISTOLOGY; LIVER REGENERATION; LIVER SURGERY; LIVER TUMOR; NONHUMAN; PORTAL VEIN BLOOD FLOW; POSTOPERATIVE PERIOD; SYSTEMATIC REVIEW; ANIMAL; ARTIFICIAL EMBOLIZATION; CYTOLOGY; HEPATIC PORTAL VEIN; LIGATION; LIVER; LIVER RESECTION; LIVER TRANSPLANTATION; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; SURGERY; VASCULAR SURGERY;

ANIMALS; CELL PROLIFERATION; CYTOKINES; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HEPATOCYTES; HUMANS; LIGATION; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; LIVER TRANSPLANTATION; MICE; PORTAL VEIN; REGENERATION; VASCULAR SURGICAL PROCEDURES;

EID: 84986877607     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i33.7613     Document Type: Article

References (78)

1. Björnsson B, Sparrelid E, Røsok B, Pomianowska E, Hasselgren K, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases-Intermediate oncological results. Eur J Surg Oncol 2016; 42: 531-537 [PMID: 26830731 DOI: 10.1016/j.ejso.2015.12.013].
2. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037-1049; discussion 1049-1051 [PMID: 15570209].
3. Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, Soubrane O, Schnitzbauer AA, Raptis D, Tschuor C, Petrowsky H, De Santibanes E, Clavien PA. Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg 2014; 260: 829-836; discussion 836-838 [PMID: 25379854 DOI: 10.1097/SLA.0000000000000947].
4. Schadde E, Ardiles V, Slankamenac K, Tschuor C, Sergeant G, Amacker N, Baumgart J, Croome K, Hernandez-Alejandro R, Lang H, de Santibanes E, Clavien PA. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: Results of a multicenter analysis. World J Surg 2014; 38: 1510-1519 [PMID: 24748319 DOI: 10.1007/s00268-014-2513-3].
5. Tschuor Ch, Croome KP, Sergeant G, Cano V, Schadde E, Ardiles V, Slankamenac K, Clariá RS, de Santibanes E, Hernandez-Alejandro R, Clavien PA. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion an extension of the ALPPS approach. Eur J Surg Oncol 2013; 39: 1230-1235 [PMID: 23994139 DOI: 10.1016/j.ejso.2013.08.009].
6. Zhang GQ, Zhang ZW, Lau WY, Chen XP. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): A new strategy to increase resectability in liver surgery. Int J Surg 2014; 12: 437-441 [PMID: 24704086 DOI: 10.1016/j.ijsu.2014.03.009].
7. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8: 347-353 [PMID: 11352309].
8. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Makuuchi M. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996; 83: 1219-1222 [PMID: 8983610].
9. Gock M, Eipel C, Linnebacher M, Klar E, Vollmar B. Impact of portal branch ligation on tissue regeneration, microcirculatory response and microarchitecture in portal blood-deprived and undeprived liver tissue. Microvasc Res 2011; 81: 274-280 [PMID: 21397614 DOI: 10.1016/j.mvr.2011.03.005].
10. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012; 255: 405-414 [PMID: 22330038 DOI: 10.1097/SLA.0b013e31824856f5].
11. de Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: The "ALPPS" approach. Ann Surg 2012; 255: 415-417 [PMID: 22330039 DOI: 10.1097/SLA.0b013e318248577d].
12. Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. Transplantation of a donor liver to 2 recipients splitting transplantation a new method in the further development of segmental liver transplantation. Langenbecks Arch Chir 1988; 373: 127-130 [PMID: 3287073].
13. Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, Abdalla EK, Hernandez-Alejandro R, Jovine E, Machado M, Malago M, Robles-Campos R, Petrowsky H, Santibanes ED, Clavien PA. Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry. Ann Surg 2015; 262: 780-785; discussion 785-786 [PMID: 26583666 DOI: 10.1097/SLA.0000000000001450].
14. Schadde E, Schnitzbauer AA, Tschuor C, Raptis DA, Bechstein WO, Clavien PA. Systematic review and meta-Analysis of feasibility, safety, and efficacy of a novel procedure: Associating liver partition and portal vein ligation for staged hepatectomy. Ann Surg Oncol 2015; 22: 3109-3120 [PMID: 25448799 DOI: 10.1245/s10434-014-4213-5].
15. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR. Preoperative portal vein embolization for major liver resection: A meta-Analysis. Ann Surg 2008; 247: 49-57 [PMID: 18156923 DOI: 10.1097/SLA.0b013e31815f6e5b].
16. Ratti F, Schadde E, Masetti M, Massani M, Zanello M, Serenari M, Cipriani F, Bonariol L, Bassi N, Aldrighetti L, Jovine E. Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy. Ann Surg Oncol 2015; 22: 1933-1942 [PMID: 25564160 DOI: 10.1245/s10434-014-4291-4].
17. Bertens KA, Hawel J, Lung K, Buac S, Pineda-Solis K, Hernandez- Alejandro R. ALPPS: challenging the concept of unresectabilitya systematic review. Int J Surg 2015; 13: 280-287 [PMID: 25496851 DOI: 10.1016/j.ijsu.2014.12.008].
18. Fard-Aghaie MH, Stavrou GA, Schuetze KC, Papalampros A, Donati M, Oldhafer KJ. ALPPS and simultaneous right hemicolectomy - step one and resection of the primary colon cancer. World J Surg Oncol 2015; 13: 124 [PMID: 25881177 DOI: 10.1186/s12957-015-0544-3].
19. Petrou A, Moris D, Kountourakis P, Fard-Aghaie M, Neofytou K, Felekouras E, Papalampros A. The ALPPS procedure as a novel "liver-first" approach in treating liver metastases of colon cancer: The first experience in Greek Cypriot area. World J Surg Oncol 2016; 14: 67 [PMID: 26956733 DOI: 10.1186/s12957-016-0827-3].
20. Chan AC, Poon RT, Chan C, Lo CM. Safety of ALPPS Procedure by the Anterior Approach for Hepatocellular Carcinoma. Ann Surg 2016; 263: E14-e16 [PMID: 26079914 DOI: 10.1097/SLA.0000000000001272].
21. Moris D, Dimitroulis D, Papalampros A, Petrou A, Felekouras E. ALPPS Procedure for Hepatocellular Carcinoma in Patients With Chronic Liver Disease: Revealing a Terra Incognita. Ann Surg 2016; Epub ahead of print [PMID: 27433912 DOI: 10.1097/SLA.0000000000001890].
22. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-847 [PMID: 15459664 DOI: 10.1038/nrm1489].
23. Fausto N. Liver regeneration. J Hepatol 2000; 32: 19-31 [PMID: 10728791].
24. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213: 286-300 [PMID: 17559071 DOI: 10.1002/jcp.21172].
25. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60-66 [PMID: 9082986].
26. Grisham JW. A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3. Cancer Res 1962; 22: 842-849 [PMID: 13902009].
27. Moolten FL, Bucher NL. Regeneration of rat liver: Transfer of humoral agent by cross circulation. Science 1967; 158: 272-274 [PMID: 6053886].
28. Okano J, Shiota G, Matsumoto K, Yasui S, Kurimasa A, Hisatome I, Steinberg P, Murawaki Y. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem Biophys Res Commun 2003; 309: 298-304 [PMID: 12951049].
29. Tomiya T, Ogata I, Yamaoka M, Yanase M, Inoue Y, Fujiwara K. The mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous transforming growth factor-Alpha. Am J Pathol 2000; 157: 1693-1701 [PMID: 11073828].
30. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N. Angiogenesis-independent endothelial protection of liver: Role of VEGFR-1. Science 2003; 299: 890-893 [PMID: 12574630 DOI: 10.1126/science.1079562].
31. Taub R, Greenbaum LE, Peng Y. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis 1999; 19: 117-127 [PMID: 10422195 DOI: 10.1055/s-2007-1007104].
32. Haber BA, Mohn KL, Diamond RH, Taub R. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 1993; 91: 1319-1326 [PMID: 8473485 DOI: 10.1172/JCI116332].
33. Kelley-Loughnane N, Sabla GE, Ley-Ebert C, Aronow BJ, Bezerra JA. Independent and overlapping transcriptional activation during liver development and regeneration in mice. Hepatology 2002; 35: 525-534 [PMID: 11870364 DOI: 10.1053/jhep.2002.31351].
34. Behrens A, Sibilia M, David JP, Möhle-Steinlein U, Tronche F, Schütz G, Wagner EF. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 2002; 21: 1782-1790 [PMID: 11927562 DOI: 10.1093/emboj/21.7.1782].
35. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383 [PMID: 8910279].
36. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, Demetris AJ. Mitosis and apoptosis in the liver of interleukin-6- deficient mice after partial hepatectomy. Hepatology 1999; 29: 403-411 [PMID: 9918916 DOI: 10.1002/hep.510290244].
37. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller- Newen G, Schaper F. Principles of interleukin (IL)-6-Type cytokine signalling and its regulation. Biochem J 2003; 374: 1-20 [PMID: 12773095 DOI: 10.1042/BJ20030407].
38. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997; 94: 1441-1446 [PMID: 9037072].
39. Fujita J, Marino MW, Wada H, Jungbluth AA, Mackrell PJ, Rivadeneira DE, Stapleton PP, Daly JM. Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice. Surgery 2001; 129: 48-54 [PMID: 11150033].
40. Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que X, Zamir GA, Hiroyasu S, Kovalovich KK, Taub R, Olthoff KM. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology 2002; 35: 40-48 [PMID: 11786958 DOI: 10.1053/jhep.2002.30081].
41. Mortensen KE, Revhaug A. Liver regeneration in surgical animal models - A historical perspective and clinical implications. Eur Surg Res 2011; 46: 1-18 [PMID: 21135558 DOI: 10.1159/000321361].
42. Schlegel A, Lesurtel M, Melloul E, Limani P, Tschuor C, Graf R, Humar B, Clavien PA. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration. Ann Surg 2014; 260: 839-46; discussion 846-7 [PMID: 25379855 DOI: 10.1097/SLA.0000000000000949].
43. Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol 2011; 26 Suppl 1: 203-212 [PMID: 21199532 DOI: 10.1111/j.1440-1746.2010.06539.x].
44. Abshagen K, Eipel C, Vollmar B. A critical appraisal of the hemodynamic signal driving liver regeneration. Langenbecks Arch Surg 2012; 397: 579-590 [PMID: 22311102 DOI: 10.1007/s00423-012-0913-0].
45. Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: A review. World J Surg 2007; 31: 367-374 [PMID: 17219273 DOI: 10.1007/s00268-006-0526-2].
46. Mortensen KE, Conley LN, Nygaard I, Sorenesen P, Mortensen E, Bendixen C, Revhaug A. Increased sinusoidal flow is not the primary stimulus to liver regeneration. Comp Hepatol 2010; 9: 2 [PMID: 20148099 DOI: 10.1186/1476-5926-9-2].
47. Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski- Berdien G, Rogiers X, Broering DC. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008; 247: 825-834 [PMID: 18438120 DOI: 10.1097/SLA.0b013e31816a9d7c].
48. Tanaka K, Endo I. ALPPS: Short-Term Outcome and Functional Changes in the Future Liver Remnant. Ann Surg 2015; 262: E88-e89 [PMID: 25133931 DOI: 10.1097/SLA.0000000000000665].
49. Tanaka K, Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Endo I, Ichikawa Y, Taguri M, Tanabe M. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-Term outcome, functional changes in the future liver remnant, and tumor growth activity. Eur J Surg Oncol 2015; 41: 506-512 [PMID: 25704556 DOI: 10.1016/j.ejso.2015.01.031].
50. Gall TM, Sodergren MH, Frampton AE, Fan R, Spalding DR, Habib NA, Pai M, Jackson JE, Tait P, Jiao LR. Radio-frequencyassisted Liver Partition with Portal vein ligation (RALPP) for liver regeneration. Ann Surg 2015; 261: E45-e46 [PMID: 24670841 DOI: 10.1097/SLA.0000000000000607].
51. van Lienden KP, Hoekstra LT, Bennink RJ, van Gulik TM. Intrahepatic left to right portoportal venous collateral vascular formation in patients undergoing right portal vein ligation. Cardiovasc Intervent Radiol 2013; 36: 1572-1579 [PMID: 23483283 DOI: 10.1007/s00270-013-0591-5].
52. Denys AL, Abehsera M, Sauvanet A, Sibert A, Belghiti J, Menu Y. Failure of right portal vein ligation to induce left lobe hypertrophy due to intrahepatic portoportal collaterals: successful treatment with portal vein embolization. AJR Am J Roentgenol 1999; 173: 633-635 [PMID: 10470893 DOI: 10.2214/ajr.173.3.10470893].
53. Yamakado K, Takeda K, Nishide Y, Jin J, Matsumura K, Nakatsuka A, Hirano T, Kato N, Nakagawa T. Portal vein embolization with steel coils and absolute ethanol: A comparative experimental study with canine liver. Hepatology 1995; 22: 1812-1818 [PMID: 7489993].
54. Dhar DK, Mohammad GH, Vyas S, Broering DC, Malago M. A novel rat model of liver regeneration: possible role of cytokine induced neutrophil chemoattractant-1 in augmented liver regeneration. Ann Surg Innov Res 2015; 9: 11 [PMID: 26535054 DOI: 10.1186/s13022-015-0020-3].
55. Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 2013; 217: 126-133; discussion 133-134 [PMID: 23632095 DOI: 10.1016/j.jamcollsurg.2013.03.004].
56. Meyer IA, Vandoni RE, Alerci M, Raptis DA, Gertsch P. Portal Vein Embolization Followed by Liver Resection versus Liver Resection Alone: A Comparison of Liver Regeneration Dynamics. Hepatogastroenterology 2015; 62: 987-991 [PMID: 26902042].
57. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-322 [PMID: 10653597 DOI: 10.1002/(SICI)1097-4652(200003)182::3<311::AIDJCP1> 3.0.CO;2-9].
58. Wei W, Zhang T, Zafarnia S, Schenk A, Xie C, Kan C, Dirsch O, Settmacher U, Dahmen U. Establishment of a rat model: Associating liver partition with portal vein ligation for staged hepatectomy. Surgery 2016; 159: 1299-1307 [PMID: 26879073 DOI: 10.1016/j.surg.2015.12.005].
59. García-Pérez R, Revilla-Nuin B, Martínez CM, Bernabé-García A, Baroja Mazo A, Parrilla Paricio P. Associated Liver Partition and Portal Vein Ligation (ALPPS) vs Selective Portal Vein Ligation (PVL) for Staged Hepatectomy in a Rat Model. Similar Regenerative Response? PLoS One 2015; 10: E0144096 [PMID: 26630386 DOI: 10.1371/journal.pone.0144096].
60. Shi H, Yang G, Zheng T, Wang J, Li L, Liang Y, Xie C, Yin D, Sun B, Sun J, Wang H, Pan S, Jiang H, Lau W, Liu L. A preliminary study of ALPPS procedure in a rat model. Sci Rep 2015; 5: 17567 [PMID: 26631552 DOI: 10.1038/srep17567].
61. Chan A, Chung PH, Poon RT. Little girl who conquered the "ALPPS". World J Gastroenterol 2014; 20: 10208-10211 [PMID: 25110450 DOI: 10.3748/wjg.v20.i29.10208].
62. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Ohta K, Yamaguchi T, Matsubara T, Takahashi T, Nakajima T, Muto T, Ikari T, Yanagisawa A, Kato Y. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34: 267-272 [PMID: 11481611 DOI: 10.1053/jhep.2001.26513].
63. Fukami Y, Kurumiya Y, Kobayashi S. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): An analysis of tumor activity. Updates Surg 2014; 66: 223-225 [PMID: 24864037 DOI: 10.1007/s13304-014-0256-1].
64. Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Yamazaki K, Ishida Y, Tanaka K. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization. Surgery 2016; 159: 1289-1298 [PMID: 26775576 DOI: 10.1016/j.surg.2015.12.004].
65. Schwabe RF, Bradham CA, Uehara T, Hatano E, Bennett BL, Schoonhoven R, Brenner DA. c-Jun-N-Terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 2003; 37: 824-832 [PMID: 12668975 DOI: 10.1053/jhep.2003.50135].
66. Nelsen CJ, Rickheim DG, Tucker MM, Hansen LK, Albrecht JH. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J Biol Chem 2003; 278: 3656-3663 [PMID: 12446670 DOI: 10.1074/jbc.M209374200].
67. Clavien PA, Lillemoe KD. Note from the editors on the ALPPS e-Letters-To-The-Editor. Ann Surg 2012; 256: 552 [PMID: 22895352 DOI: 10.1097/SLA.0b013e318266fa1f].
68. Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J. Right portal vein ligation: A new planned two-step allsurgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 2003; 197: 164-170 [PMID: 12831938 DOI: 10.1016/S1072- 7515(03)00334-X].
69. Niehues SM, Unger JK, Malinowski M, Neymeyer J, Hamm B, Stockmann M. Liver volume measurement: Reason of the difference between in vivo CT-volumetry and intraoperative ex vivo determination and how to cope it. Eur J Med Res 2010; 15: 345-350 [PMID: 20947471].
70. Yao L, Li C, Ge X, Wang H, Xu K, Zhang A, Dong J. Establishment of a rat model of portal vein ligation combined with in situ splitting. PLoS One 2014; 9: E105511 [PMID: 25144490 DOI: 10.1371/journal.pone.0105511].
71. Almau Trenard HM, Moulin LE, Padín JM, Stringa P, Gondolesi GE, Barros Schelotto P. Development of an experimental model of portal vein ligation associated with parenchymal transection (ALPPS) in rats. Cir Esp 2014; 92: 676-681 [PMID: 25064517 DOI: 10.1016/j.ciresp.2013.11.005].
72. Røsok BI, Björnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bjørnbeth BA, Isaksson B, Sandström P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery 2016; 159: 1279-1286 [PMID: 26606881 DOI: 10.1016/j.surg.2015.10.004].
73. von Heesen M, Hülser M, Seibert K, Scheuer C, Dold S, Kollmar O, Wagner M, Menger MD, Schilling MK, Moussavian MR. Splitliver procedure and inflammatory response: improvement by pharmacological preconditioning. J Surg Res 2011; 168: E125-e135 [PMID: 21435665 DOI: 10.1016/j.jss.2011.01.036].
74. Michalopoulos GK. Principles of liver regeneration and growth homeostasis. Compr Physiol 2013; 3: 485-513 [PMID: 23720294 DOI: 10.1002/cphy.c120014].
75. Miyaoka Y, Miyajima A. To divide or not to divide: Revisiting liver regeneration. Cell Div 2013; 8: 8 [PMID: 23786799 DOI: 10.1186/1747-1028-8-8].
76. Kaibori M, Yanagida H, Nakanishi H, Ozaki T, Yoshida H, Matsui K, Hijikawa T, Kamiyama Y, Okumura T. Hepatocyte growth factor stimulates the induction of cytokine-induced neutrophil chemoattractant through the activation of NF-kappaB in rat hepatocytes. J Surg Res 2006; 130: 88-93 [PMID: 16271365 DOI: 10.1016/j.jss.2005.09.025].
77. Zhang C, Li Y, Wu Y, Wang L, Wang X, Du J. Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J Biol Chem 2013; 288: 1489-1499 [PMID: 23184935 DOI: 10.1074/jbc.M112.419788].
78. Tanaka H, Kinoshita H, Hirohashi K, Kubo S, Lee KC. Increased safety by two-stage hepatectomy with preoperative portal vein embolization in rats. J Surg Res 1994; 57: 687-692 [PMID: 7996847 DOI: 10.1006/jsre.1994.1202].